Wed, Sep 17, 2014, 6:11 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • laujhawj laujhawj Nov 16, 2012 2:51 PM Flag

    3 More Delays

    and with Management saying they will wait for the 7th decision from the FDA on NCE and we could be having a $4 stock!

    On the upside, it'd be really cheap at the price range!

    This is the work of imbeciles who can't even follow their own simple definitional guidelines, on what an "active moiety" is or is not... For a lot of people, they can stitch on all sorts of labels and titles on their breast pockets, or forehead, and they are still imbeciles.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Is the clock running from July for the 5 years exclusivity? If so the FDA has waisted 4 months and now December will be 5 months of exclusitive.

      I read where the FDA ruled on a drug that it was a moot point to exclusitivity as the exclusitivity period had expired.

      If the clock is running, then Amarin should take the three years and go with it unless while we wait it keeps the generic drug makers at bay afraid of a positive ruling. Otherwise, the generic drug makers should start asking to produce generic as Amarin at the current time does not have 3 or 5 years exclusivity.

 
AMRN
1.37+0.02(+1.48%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.